PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: IMARC Group

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Indian HIV Diagnostic Market Expected to Grow Exponentially Finds IMARC Group - Although elisa based tests currently dominate this market, the popularity of rapid tests as a result of their ease of use and faster results is increasing rapidly in the country - IMARCgroup.com
Indian HIV Diagnostic Market Expected to Grow Exponentially Finds IMARC Group

 

NewswireToday - /newswire/ - Noida, Uttar Pradesh, India, 2012/04/27 - Although elisa based tests currently dominate this market, the popularity of rapid tests as a result of their ease of use and faster results is increasing rapidly in the country - IMARCgroup.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

A new report from IMARC Group entitled “Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016” finds that the market for HIV diagnostics is expected to grow exponentially in the coming years. Findings from the report suggest that although elisa based tests currently dominate this market, the popularity of rapid tests as a result of their ease of use and faster results is increasing rapidly in the country.

Apart from HIV, the report has also done a comprehensive analysis on the current and future potential of immunology based diagnostic tests for Hepatitis B, Hepatitis C, Tuberculosis, Dengue, Syphilis and Oncology. Metrics such as number of tests conducted each year, breakup by type of tests, current & future market sales, average cost of tests and the names key players has been provided for each indication in the report.

Key Questions Answered in this Report:

• What is the current size and growth of the Indian Immunodiagnostics market?
• What are the most popular types of Immunodiagnostic tests conducted in India?
• What are the most popular indications for which Immunodiagnostic tests are conducted?
• Who are the key players operating in the Indian Immunodiagnostics market?
• What are the various regulations in the Indian Immunodiagnostics market?
• What are the strengths, weaknesses, opportunities and threats in the Indian Immunodiagnostics Market?
• What is the prevalence of Elisa and Rapid tests for each Indication?
• What is the future of Immunodiagnostics in India?
• What is the current and future landscape of HIV diagnostics in India?
• What is the current and future landscape of Hepatitis B diagnostics in India?
• What is the current and future landscape of Hepatitis C diagnostics in India?
• What is the current and future landscape of Tuberculosis diagnostics in India?
• What is the current and future landscape of Dengue diagnostics in India?
• What is the current and future landscape of Syphilis diagnostics in India?
• What is the current and future landscape of Cancer diagnostics in India?

Key Aspects Analyzed:
Diagnostic Antibodies
Understanding the strengths, weaknesses, opportunities and challenges in the Indian diagnostic antibodies market
Understanding the technological considerations and regulatory factors in the Indian diagnostic antibodies market
• Evaluating the various types of antibody based diagnostic tests conducted in India and analyzing their strengths and weaknesses.
• Understanding the key regulations for registering, manufacturing and importing diagnostics in India.
Comprehensive situation analysis of the Indian diagnostic antibodies market
Segments covered: HIV, Hepatitis B, Hepatitis C, Tuberculosis, Dengue, Syphilis and Oncology

Focus of the analysis in each segment:
• Number of tests conducted each year;
• Breakup by type of tests conducted;
• Current and future market sales;
• Average cost of diagnostic tests;
• Key players operating in the market.

Therapeutic Antibodies
Understanding the strengths, weaknesses, opportunities and challenges in the Indian therapeutic antibodies market

Understanding the technological considerations and regulatory factors in the Indian therapeutic antibodies market
• Evaluation and identification of monoclonal antibodies based on the sources from which they are derived and on the targets against which they act.
• Understanding the key regulations for registering, manufacturing and importing therapeutic antibodies in India.

Evaluating the patent details of all globally marketed monoclonal antibodies in India, US and Europe
• Identifying the patentee name and patent numbers of all in-market monoclonal antibodies in India, US and Europe.
• Identifying the monoclonal antibodies that are patent protected in India, US and Europe and those that are not.
• Estimating the patent expiries of various monoclonal antibodies in India, US and Europe.

Comprehensive situation analysis of the Indian therapeutic antibodies market
• Analyzing current and future sales of monoclonal antibodies in India.
• Identifying all globally launched monoclonal antibodies and understanding their performance and launch status in India.
• Analyzing the global and Indian monoclonal antibodies market by Indication.
• Evaluation of the top selling monoclonal antibodies.
• Key biosimilar antibody development programmes in India and abroad.

Contact:

IMARC Group Asia
E: apac[.]imarcgroup.com - P: +91 120-425-6531

IMARC Group North America
E: america[.]imarcgroup.com - P: +1 631-791-1145

IMARC Group Europe, Middle East & Africa
E: ema[.]imarcgroup.com - P: +44(0)70 2409-7331

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: IMARC Group

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Indian HIV Diagnostic Market Expected to Grow Exponentially Finds IMARC Group

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Krishna Sharma - IMARCgroup.com 
+91 12 04155099
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any IMARC Group securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From IMARC Group / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)